Surging Demand for Non-Pharmacological Therapies and Advancements in Neurostimulation Technologies Fuel Market Expansion ...

Nalu Medical, Inc. ("Nalu") announced today the appointment of Raymond W. Cohen to serve as chairman of its board of directors. Raymond Cohen served as the chief executive officer and member of the ...

The Nalu Neurostimulation System delivers gentle electrical pulses ... It is FDA-cleared for Peripheral Nerve Stimulation (PNS) and Spinal Cord Stimulation (SCS) indications. To learn more, visit ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Segmentation Analysis Highlighted with 97 tables and 100 figures, this 190-page report represents a 360-degree view on the global market with extensively detailed segmentations by Product, Technology, ...

None of this was possible until Stanford researchers developed it in 2015 by implanting the first-generation sensing neurostimulators. Now, the personalisd treatment is poised to touch millions of ...

and neurostimulators at the Heart Rhythm Society’s annual meeting (HRS 2025). Attendees will have the opportunity to experience firsthand the soft, conforming feel of EluPro and discover how its ...

QoL improved according to narrative reports, and the increases in FS, SCS, and RRM were significantly higher than the meaningful threshold, ranging from 2-fold (RRM 31-40) to 3-fold (FS 39-48) to ...

Hyporeflexia is the reduction or absence of the body's normal reflexes. It is caused by the disruptions of signals from nerve cells of the spinal cord (called motor neurons) to skeletal muscles that ...